Schizophrenia Trial, Recruiting NCT04414215 Sponsor: University of Georgia Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT04414215
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with schizophrenia or schizoaffective disorder according to current standard diagnostic guidelines (DSM-5)
  • People aged between 18 and 60 years old
  • People who speak English
  • People whose level of intellectual functioning before their illness was estimated to be within the general range (an IQ above 70)
  • People whose condition has been stable, meaning no changes to their antipsychotic medication in the past month, or in the past two months if their medication is given as a long-acting injection

Who may not be able to join:

  • People with a history of intellectual disability or a neurological condition affecting the brain or nervous system
  • People with a history of a traumatic brain injury where they lost consciousness for more than 10 minutes, or where the injury caused lasting changes to their behaviour
  • People who have had a diagnosis of substance use disorder (other than nicotine) within the last 6 months
  • People who have factors that would prevent them from safely having an MRI scan (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 706-542-0307

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Georgia
Registry
ClinicalTrials.gov
Start date
1 June 2020
Est. completion
31 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Prefrontal blood oxygen level dependent activation in the prefrontal cortex

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov